// App-Quantinova.ai

P624 : CHROMOTHRIPSIS IN PATIENTS WITH CLL AND COMPLEX KARYOTYPE: PATTERNS OF ABERRATIONS AND PROGNOSTIC VALUE

Researchers

Presenter

  • Silvia Ramos-Campoy

Principal Investigators

  • Anna Puiggros

  • Slvia Be

  • Dolors Costa

  • Helen Parker

  • Gian Matteo Rigolin

  • Rosa Collado

  • Tycho Baumann

  • Eva Gimeno

  • Carol Moreno

  • Mara Jos Calasanz

  • Antonio Cuneo

  • Jonathan C Strefford

  • Florence Nguyen-Khac

  • David Oscier

  • Claudia Haferlach

  • Jacqueline Schoumans

  • Blanca Espinet

Medical Centers

  • Department of Hematology and Hemotherapy, Hospital Univ

  • Hematology Secti

  • Department of Hematology and Hemotherapy, Hospital Universitario Cruces,Bilbao,Spain

  • Department of Molecular Pathology, Royal B

  • Department of Genetics, Universidad de Navarra,Pamplona,Spanien

  • Hematology Department and Sorbonne University, Hôpital Pitié-Salpêtrière, APHP, INSERM U1138,Paris,France

  • Department of Genetics, Universidad de Navarra,Pamplona,Spanien

  • Hematology Section, St. Anna University Hospital,Ferrara,Italië

  • Pneumology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain

  • Department of Genetics, Universidad de Navarra,Pamplona,Spanien

  • Department of Hematology, Fundación Jiménez Díaz,Madrid,Spanje

  • Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain

  • Department of Hematology, Hospital Universitario Central de Asturia

  • Hematology Section, St. Anna University Hospital,Ferrara,Italië

  • Hematology Section, St. Anna University Hospital,Ferrara,Italië

  • Oncogenomic Laboratory, Hematology Service,Lausanne University Hospital,Lausanne,Switzerland

  • Molecular Cytogenetics Laboratory, Pathology Department,Hospital del Mar,Barcelona,Spain

  • Oncogenomic Laboratory, Hematology S

  • Hematology Section, St. Anna University Hospital,Ferrara,Italië

  • MLL Munich Leukemia Laboratory,München,Germania

  • Department of Medical Oncology Consorcio Hospital General Universitario de Valencia, Spain, Valencia, Spain

  • Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain

  • Molecular Cytogenetics Laboratory, Pathology Department,Hospital del Mar,Barcelona,Spain

  • Cancer Sciences, Faculty of Medicine, University of Southampton,Southampton,Royaume-uni

  • Pneumology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain

  • MLL Munich Leukemia Laboratory,Munich,Германия

  • Department of Medical Oncology Consorcio Hospital General Universitario de Valencia, Spain, Valencia, Spain

  • Cancer Sciences, Faculty of Medici

  • Hematology Section, St. Anna University Hospital,Ferrara,Italië

  • Pneumology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain

  • Hematology Department and Sorbonne University, Hôpital Pitié-Salpêtrière, APHP, INSERM U1138,Paris,France

  • Molecular Cytogenetics Laboratory, Pathology Department,Hospital del Mar,Barcelona,Spain

  • Molecular Cytogenetics Laboratory, Pathology Department,Hospital del Mar,Barcelona,Spain

  • Department of Hematology, Fundación Jiménez Díaz,Madrid,Spanje

  • MLL Munich Leukemia Laboratory,München,Germania

  • Cancer Sciences, Faculty of Medicine, University of Southampton,Southampton,Royaume-uni

  • MLL Munich Leukemia Laboratory,München,Germania

  • Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain

  • Hematology Department and Sorbonne University, Hôpital Pitié-Salpêtrière, APHP, INSERM U1138,Paris,France

  • Cancer Sciences, Faculty of Medicine, University of Southampton,Southampton,Royaume-uni

  • Department of Hematology, Fundación Jiménez Díaz,Madrid,Spanje

  • Department of Hematology, Consorcio Hospital General Universitario,

  • Department of Hematology, Fundación Jiménez Díaz,Madrid,Spanje

  • Munich Leukemia Laboratory, Munich, Germany.

  • Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain

  • Department of Hematology,

  • Department of Molecular Pathology, Royal Bournemouth Hospital,Bournemouth,Royaume-uni

  • Molecular Cytogenetics Laboratory,

  • Oncogenomic Laboratory, Hematology Service,Lausanne University Hospital,Lausanne,Switzerland

  • Oncogenomic Laboratory, Hematology Service,Lausanne University Hospital,Lausanne,Switzerland

  • Department of Hematology and Hemotherapy, Hospital Universitario Cruces,Bilbao,Spain

  • Department of Hematology, Hospital Universitari de la Santa Creu i Sant Pau,Barcelona,Espagne

  • Department of Medical Oncology Consorcio Hospital General Universitario de Valencia, Spain, Valencia, Spain

  • Munich Leukemia Laboratory, Munich, Germany.

  • Department of Genetics, Universidad de Navarra,Pamplona,Spanien

  • Department of Hematology, Fundación Jiménez Díaz,Madrid,Spanje

  • Department of Hematology, Fundación Jiménez Díaz,Madrid,Spanje

  • Oncogenomic Laboratory, Hematology Service,Lausanne University Hospital,Lausanne,Switzerland

  • Department of Haematology,Royal Bournemouth Hospital,Bournemouth,Vereinigtes Königreich

  • MLL Munich Leukemia

  • Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain

  • Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain

  • Department of Medical Oncology Consorcio Hospital General Universitario de Valencia, Spain, Valencia, Spain

  • Department of Genetics, Universidad de Navarra,Pamplona,Spanien

  • Hematopathology Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona, Spain

  • Department of Genetics,

  • Department of Hematology and Hemotherapy, Hospital Universitario Cruces,Bilbao,Spain

  • Department of Hematology,

  • MLL Munich Leukemia Laboratory,München,Germania

  • Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • Hematology Department and Sorbonne University, Hôpital Pitié-Salpêtrière, APH

  • Dept of Molecular Pathology,Royal Bournemouth Hospital,Bournemouth,United Kingdom

  • Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom

  • Department of Hematology and Hemotherapy, Hospital Universitario Cruces,Bilbao,Spain

  • Department of Genetics, Universidad de Navarra,Pamplona,Spanien

Locations

  • Venezuela

  • Spain

  • Switzerland

  • United Kingdom

  • Italy

  • Cuba

  • United States

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved